Table 3.
Bangladesh | Ethiopia | |||
---|---|---|---|---|
Value | Source | Value | Source | |
Number of women of reproductive age (15–49) (‘000) | 44,998a | UN data 2017 [34] | 24,150a | UN data 2017 [34] |
Fertility rate of women of reproductive age (15–49) | 73a | DHS 2015 [35] | 141a | DHS 2016 [36] |
Maternal mortality ratiob | 205a | BMMS 2016 [13] | 412 | EmONC assessment 2016 [17] |
Maternal deaths due to PPH | 27%a | BMMS 2016 [13] | 31% | EmONC assessment 2016 [17] |
Child survival rate (to age of 12 months) | ||||
If mother survives | 92.4% | Ronsmans et al. 2010 [37] | 95.6% | Moucheraud et al. 2015 [38] |
If mother dies within 42 days of childbirth | 29.6% | Ronsmans et al. 2010 [37] | 18.75% | Moucheraud et al. 2015 [38] |
Incidence of PPH without preventative uterotonics | ||||
Mild | 11.3% | Gallos et al. 2018 [8] | 11.3% | Gallos et al. 2018 [8] |
Severe | 5.9% | Gallos et al. 2018 [8] | 5.9% | Gallos et al. 2018 [8] |
Risk ratio of mild PPH with uterotonics for prevention | ||||
Injectable oxytocin | 0.61 | Gallos et al. 2018 [8] | 0.61 | Gallos et al. 2018 [8] |
Misoprostol | 0.75 | Gallos et al. 2018 [8] | 0.75 | Gallos et al. 2018 [8] |
Inhaled oxytocin | 0.61 | Assumption | 0.61 | Assumption |
Risk ratio of severe PPH with uterotonics for prevention | ||||
Injectable oxytocin | 0.61 | Gallos et al. 2018 [8] | 0.61 | Gallos et al. 2018 [8] |
Misoprostol | 0.73 | Gallos et al. 2018 [8] | 0.73 | Gallos et al. 2018 [8] |
Inhaled oxytocin | 0.61 | Assumption | 0.61 | Assumption |
UN United Nations, DHS Demographic and Health Survey, BMMS Bangladesh Maternal Mortality Survey, EmONC Emergency Obstetric and Neonatal Care, PPH postpartum haemorrhage
aAge-specific values used (5-year brackets)
bDeaths per 100,000 live births